Global Anti-Aging Drugs and Devices Market Research Report 2024

Anti-Aging Drugs and Devices Market

Botox and filler treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Anti-Aging Drugs and Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Aging Drugs and Devices.

Report Scope

The Anti-Aging Drugs and Devices market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Aging Drugs and Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anti-Aging Drugs and Devices companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

PrivateLabelSk

Allergan

Johnson and Johnson

Alma Lasers

Photomedex

Estée Lauder

Lumenis

Solta Medical

Beiersdorf

Cynosure

Procter & Gamble and L'Oréal

Drugs

Devices

Skin and Hair

Skeletal and Muscles

Age Related Disorders and Others

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Scope of Anti-Aging Drugs and Devices Market Report

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-Aging Drugs and Devices companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Anti-Aging Drugs and Devices Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Drugs

1.2.3 Devices

1.3 Market by Application

1.3.1 Global Anti-Aging Drugs and Devices Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Skin and Hair

1.3.3 Skeletal and Muscles

1.3.4 Age Related Disorders and Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Anti-Aging Drugs and Devices Market Perspective (2019-2030)

2.2 Anti-Aging Drugs and Devices Growth Trends by Region

2.2.1 Global Anti-Aging Drugs and Devices Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Anti-Aging Drugs and Devices Historic Market Size by Region (2019-2024)

2.2.3 Anti-Aging Drugs and Devices Forecasted Market Size by Region (2025-2030)

2.3 Anti-Aging Drugs and Devices Market Dynamics

2.3.1 Anti-Aging Drugs and Devices Industry Trends

2.3.2 Anti-Aging Drugs and Devices Market Drivers

2.3.3 Anti-Aging Drugs and Devices Market Challenges

2.3.4 Anti-Aging Drugs and Devices Market Restraints

3.1 Global Top Anti-Aging Drugs and Devices Players by Revenue

3.1.1 Global Top Anti-Aging Drugs and Devices Players by Revenue (2019-2024)

3.1.2 Global Anti-Aging Drugs and Devices Revenue Market Share by Players (2019-2024)

3.2 Global Anti-Aging Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Anti-Aging Drugs and Devices Revenue

3.4 Global Anti-Aging Drugs and Devices Market Concentration Ratio

3.4.1 Global Anti-Aging Drugs and Devices Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Anti-Aging Drugs and Devices Revenue in 2023

3.5 Anti-Aging Drugs and Devices Key Players Head office and Area Served

3.6 Key Players Anti-Aging Drugs and Devices Product Solution and Service

3.7 Date of Enter into Anti-Aging Drugs and Devices Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Anti-Aging Drugs and Devices Historic Market Size by Type (2019-2024)

4.2 Global Anti-Aging Drugs and Devices Forecasted Market Size by Type (2025-2030)

5.1 Global Anti-Aging Drugs and Devices Historic Market Size by Application (2019-2024)

5.2 Global Anti-Aging Drugs and Devices Forecasted Market Size by Application (2025-2030)

6.1 North America Anti-Aging Drugs and Devices Market Size (2019-2030)

6.2 North America Anti-Aging Drugs and Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Anti-Aging Drugs and Devices Market Size by Country (2019-2024)

6.4 North America Anti-Aging Drugs and Devices Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7.1 Europe Anti-Aging Drugs and Devices Market Size (2019-2030)

7.2 Europe Anti-Aging Drugs and Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Anti-Aging Drugs and Devices Market Size by Country (2019-2024)

7.4 Europe Anti-Aging Drugs and Devices Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Anti-Aging Drugs and Devices Market Size (2019-2030)

8.2 Asia-Pacific Anti-Aging Drugs and Devices Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Anti-Aging Drugs and Devices Market Size by Region (2019-2024)

8.4 Asia-Pacific Anti-Aging Drugs and Devices Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Anti-Aging Drugs and Devices Market Size (2019-2030)

9.2 Latin America Anti-Aging Drugs and Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Anti-Aging Drugs and Devices Market Size by Country (2019-2024)

9.4 Latin America Anti-Aging Drugs and Devices Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Anti-Aging Drugs and Devices Market Size (2019-2030)

10.2 Middle East & Africa Anti-Aging Drugs and Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Anti-Aging Drugs and Devices Market Size by Country (2019-2024)

10.4 Middle East & Africa Anti-Aging Drugs and Devices Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 PrivateLabelSk

11.1.1 PrivateLabelSk Company Detail

11.1.2 PrivateLabelSk Business Overview

11.1.3 PrivateLabelSk Anti-Aging Drugs and Devices Introduction

11.1.4 PrivateLabelSk Revenue in Anti-Aging Drugs and Devices Business (2019-2024)

11.1.5 PrivateLabelSk Recent Development

11.2 Allergan

11.2.1 Allergan Company Detail

11.2.2 Allergan Business Overview

11.2.3 Allergan Anti-Aging Drugs and Devices Introduction

11.2.4 Allergan Revenue in Anti-Aging Drugs and Devices Business (2019-2024)

11.2.5 Allergan Recent Development

11.3 Johnson and Johnson

11.3.1 Johnson and Johnson Company Detail

11.3.2 Johnson and Johnson Business Overview

11.3.3 Johnson and Johnson Anti-Aging Drugs and Devices Introduction

11.3.4 Johnson and Johnson Revenue in Anti-Aging Drugs and Devices Business (2019-2024)

11.3.5 Johnson and Johnson Recent Development

11.4 Alma Lasers

11.4.1 Alma Lasers Company Detail

11.4.2 Alma Lasers Business Overview

11.4.3 Alma Lasers Anti-Aging Drugs and Devices Introduction

11.4.4 Alma Lasers Revenue in Anti-Aging Drugs and Devices Business (2019-2024)

11.4.5 Alma Lasers Recent Development

11.5 Photomedex

11.5.1 Photomedex Company Detail

11.5.2 Photomedex Business Overview

11.5.3 Photomedex Anti-Aging Drugs and Devices Introduction

11.5.4 Photomedex Revenue in Anti-Aging Drugs and Devices Business (2019-2024)

11.5.5 Photomedex Recent Development

11.6 Estée Lauder

11.6.1 Estée Lauder Company Detail

11.6.2 Estée Lauder Business Overview

11.6.3 Estée Lauder Anti-Aging Drugs and Devices Introduction

11.6.4 Estée Lauder Revenue in Anti-Aging Drugs and Devices Business (2019-2024)

11.6.5 Estée Lauder Recent Development

11.7 Lumenis

11.7.1 Lumenis Company Detail

11.7.2 Lumenis Business Overview

11.7.3 Lumenis Anti-Aging Drugs and Devices Introduction

11.7.4 Lumenis Revenue in Anti-Aging Drugs and Devices Business (2019-2024)

11.7.5 Lumenis Recent Development

11.8 Solta Medical

11.8.1 Solta Medical Company Detail

11.8.2 Solta Medical Business Overview

11.8.3 Solta Medical Anti-Aging Drugs and Devices Introduction

11.8.4 Solta Medical Revenue in Anti-Aging Drugs and Devices Business (2019-2024)

11.8.5 Solta Medical Recent Development

11.9 Beiersdorf

11.9.1 Beiersdorf Company Detail

11.9.2 Beiersdorf Business Overview

11.9.3 Beiersdorf Anti-Aging Drugs and Devices Introduction

11.9.4 Beiersdorf Revenue in Anti-Aging Drugs and Devices Business (2019-2024)

11.9.5 Beiersdorf Recent Development

11.10 Cynosure

11.10.1 Cynosure Company Detail

11.10.2 Cynosure Business Overview

11.10.3 Cynosure Anti-Aging Drugs and Devices Introduction

11.10.4 Cynosure Revenue in Anti-Aging Drugs and Devices Business (2019-2024)

11.10.5 Cynosure Recent Development

11.11 Procter & Gamble and L'Oréal

11.11.1 Procter & Gamble and L'Oréal Company Detail

11.11.2 Procter & Gamble and L'Oréal Business Overview

11.11.3 Procter & Gamble and L'Oréal Anti-Aging Drugs and Devices Introduction

11.11.4 Procter & Gamble and L'Oréal Revenue in Anti-Aging Drugs and Devices Business (2019-2024)

11.11.5 Procter & Gamble and L'Oréal Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Anti-Aging Drugs and Devices Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

    Table 2. Key Players of Drugs

    Table 3. Key Players of Devices

    Table 4. Global Anti-Aging Drugs and Devices Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

    Table 5. Global Anti-Aging Drugs and Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 6. Global Anti-Aging Drugs and Devices Market Size by Region (2019-2024) & (US$ Million)

    Table 7. Global Anti-Aging Drugs and Devices Market Share by Region (2019-2024)

    Table 8. Global Anti-Aging Drugs and Devices Forecasted Market Size by Region (2025-2030) & (US$ Million)

    Table 9. Global Anti-Aging Drugs and Devices Market Share by Region (2025-2030)

    Table 10. Anti-Aging Drugs and Devices Market Trends

    Table 11. Anti-Aging Drugs and Devices Market Drivers

    Table 12. Anti-Aging Drugs and Devices Market Challenges

    Table 13. Anti-Aging Drugs and Devices Market Restraints

    Table 14. Global Anti-Aging Drugs and Devices Revenue by Players (2019-2024) & (US$ Million)

    Table 15. Global Anti-Aging Drugs and Devices Market Share by Players (2019-2024)

    Table 16. Global Top Anti-Aging Drugs and Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Aging Drugs and Devices as of 2023)

    Table 17. Ranking of Global Top Anti-Aging Drugs and Devices Companies by Revenue (US$ Million) in 2023

    Table 18. Global 5 Largest Players Market Share by Anti-Aging Drugs and Devices Revenue (CR5 and HHI) & (2019-2024)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Anti-Aging Drugs and Devices Product Solution and Service

    Table 21. Date of Enter into Anti-Aging Drugs and Devices Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Anti-Aging Drugs and Devices Market Size by Type (2019-2024) & (US$ Million)

    Table 24. Global Anti-Aging Drugs and Devices Revenue Market Share by Type (2019-2024)

    Table 25. Global Anti-Aging Drugs and Devices Forecasted Market Size by Type (2025-2030) & (US$ Million)

    Table 26. Global Anti-Aging Drugs and Devices Revenue Market Share by Type (2025-2030)

    Table 27. Global Anti-Aging Drugs and Devices Market Size by Application (2019-2024) & (US$ Million)

    Table 28. Global Anti-Aging Drugs and Devices Revenue Market Share by Application (2019-2024)

    Table 29. Global Anti-Aging Drugs and Devices Forecasted Market Size by Application (2025-2030) & (US$ Million)

    Table 30. Global Anti-Aging Drugs and Devices Revenue Market Share by Application (2025-2030)

    Table 31. North America Anti-Aging Drugs and Devices Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 32. North America Anti-Aging Drugs and Devices Market Size by Country (2019-2024) & (US$ Million)

    Table 33. North America Anti-Aging Drugs and Devices Market Size by Country (2025-2030) & (US$ Million)

    Table 34. Europe Anti-Aging Drugs and Devices Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 35. Europe Anti-Aging Drugs and Devices Market Size by Country (2019-2024) & (US$ Million)

    Table 36. Europe Anti-Aging Drugs and Devices Market Size by Country (2025-2030) & (US$ Million)

    Table 37. Asia-Pacific Anti-Aging Drugs and Devices Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 38. Asia-Pacific Anti-Aging Drugs and Devices Market Size by Region (2019-2024) & (US$ Million)

    Table 39. Asia-Pacific Anti-Aging Drugs and Devices Market Size by Region (2025-2030) & (US$ Million)

    Table 40. Latin America Anti-Aging Drugs and Devices Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 41. Latin America Anti-Aging Drugs and Devices Market Size by Country (2019-2024) & (US$ Million)

    Table 42. Latin America Anti-Aging Drugs and Devices Market Size by Country (2025-2030) & (US$ Million)

    Table 43. Middle East & Africa Anti-Aging Drugs and Devices Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 44. Middle East & Africa Anti-Aging Drugs and Devices Market Size by Country (2019-2024) & (US$ Million)

    Table 45. Middle East & Africa Anti-Aging Drugs and Devices Market Size by Country (2025-2030) & (US$ Million)

    Table 46. PrivateLabelSk Company Detail

    Table 47. PrivateLabelSk Business Overview

    Table 48. PrivateLabelSk Anti-Aging Drugs and Devices Product

    Table 49. PrivateLabelSk Revenue in Anti-Aging Drugs and Devices Business (2019-2024) & (US$ Million)

    Table 50. PrivateLabelSk Recent Development

    Table 51. Allergan Company Detail

    Table 52. Allergan Business Overview

    Table 53. Allergan Anti-Aging Drugs and Devices Product

    Table 54. Allergan Revenue in Anti-Aging Drugs and Devices Business (2019-2024) & (US$ Million)

    Table 55. Allergan Recent Development

    Table 56. Johnson and Johnson Company Detail

    Table 57. Johnson and Johnson Business Overview

    Table 58. Johnson and Johnson Anti-Aging Drugs and Devices Product

    Table 59. Johnson and Johnson Revenue in Anti-Aging Drugs and Devices Business (2019-2024) & (US$ Million)

    Table 60. Johnson and Johnson Recent Development

    Table 61. Alma Lasers Company Detail

    Table 62. Alma Lasers Business Overview

    Table 63. Alma Lasers Anti-Aging Drugs and Devices Product

    Table 64. Alma Lasers Revenue in Anti-Aging Drugs and Devices Business (2019-2024) & (US$ Million)

    Table 65. Alma Lasers Recent Development

    Table 66. Photomedex Company Detail

    Table 67. Photomedex Business Overview

    Table 68. Photomedex Anti-Aging Drugs and Devices Product

    Table 69. Photomedex Revenue in Anti-Aging Drugs and Devices Business (2019-2024) & (US$ Million)

    Table 70. Photomedex Recent Development

    Table 71. Estée Lauder Company Detail

    Table 72. Estée Lauder Business Overview

    Table 73. Estée Lauder Anti-Aging Drugs and Devices Product

    Table 74. Estée Lauder Revenue in Anti-Aging Drugs and Devices Business (2019-2024) & (US$ Million)

    Table 75. Estée Lauder Recent Development

    Table 76. Lumenis Company Detail

    Table 77. Lumenis Business Overview

    Table 78. Lumenis Anti-Aging Drugs and Devices Product

    Table 79. Lumenis Revenue in Anti-Aging Drugs and Devices Business (2019-2024) & (US$ Million)

    Table 80. Lumenis Recent Development

    Table 81. Solta Medical Company Detail

    Table 82. Solta Medical Business Overview

    Table 83. Solta Medical Anti-Aging Drugs and Devices Product

    Table 84. Solta Medical Revenue in Anti-Aging Drugs and Devices Business (2019-2024) & (US$ Million)

    Table 85. Solta Medical Recent Development

    Table 86. Beiersdorf Company Detail

    Table 87. Beiersdorf Business Overview

    Table 88. Beiersdorf Anti-Aging Drugs and Devices Product

    Table 89. Beiersdorf Revenue in Anti-Aging Drugs and Devices Business (2019-2024) & (US$ Million)

    Table 90. Beiersdorf Recent Development

    Table 91. Cynosure Company Detail

    Table 92. Cynosure Business Overview

    Table 93. Cynosure Anti-Aging Drugs and Devices Product

    Table 94. Cynosure Revenue in Anti-Aging Drugs and Devices Business (2019-2024) & (US$ Million)

    Table 95. Cynosure Recent Development

    Table 96. Procter & Gamble and L'Oréal Company Detail

    Table 97. Procter & Gamble and L'Oréal Business Overview

    Table 98. Procter & Gamble and L'Oréal Anti-Aging Drugs and Devices Product

    Table 99. Procter & Gamble and L'Oréal Revenue in Anti-Aging Drugs and Devices Business (2019-2024) & (US$ Million)

    Table 100. Procter & Gamble and L'Oréal Recent Development

    Table 101. Research Programs/Design for This Report

    Table 102. Key Data Information from Secondary Sources

    Table 103. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Anti-Aging Drugs and Devices Market Size Comparison by Type (2024-2030) & (US$ Million)

    Figure 2. Global Anti-Aging Drugs and Devices Market Share by Type: 2023 VS 2030

    Figure 3. Drugs Features

    Figure 4. Devices Features

    Figure 5. Global Anti-Aging Drugs and Devices Market Size Comparison by Application (2024-2030) & (US$ Million)

    Figure 6. Global Anti-Aging Drugs and Devices Market Share by Application: 2023 VS 2030

    Figure 7. Skin and Hair Case Studies

    Figure 8. Skeletal and Muscles Case Studies

    Figure 9. Age Related Disorders and Others Case Studies

    Figure 10. Anti-Aging Drugs and Devices Report Years Considered

    Figure 11. Global Anti-Aging Drugs and Devices Market Size (US$ Million), Year-over-Year: 2019-2030

    Figure 12. Global Anti-Aging Drugs and Devices Market Size, (US$ Million), 2019 VS 2023 VS 2030

    Figure 13. Global Anti-Aging Drugs and Devices Market Share by Region: 2023 VS 2030

    Figure 14. Global Anti-Aging Drugs and Devices Market Share by Players in 2023

    Figure 15. Global Top Anti-Aging Drugs and Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Aging Drugs and Devices as of 2023)

    Figure 16. The Top 10 and 5 Players Market Share by Anti-Aging Drugs and Devices Revenue in 2023

    Figure 17. North America Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 18. North America Anti-Aging Drugs and Devices Market Share by Country (2019-2030)

    Figure 19. United States Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 20. Canada Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 21. Europe Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 22. Europe Anti-Aging Drugs and Devices Market Share by Country (2019-2030)

    Figure 23. Germany Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 24. France Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 25. U.K. Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 26. Italy Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 27. Russia Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 28. Nordic Countries Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 29. Asia-Pacific Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 30. Asia-Pacific Anti-Aging Drugs and Devices Market Share by Region (2019-2030)

    Figure 31. China Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 32. Japan Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 33. South Korea Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 34. Southeast Asia Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 35. India Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 36. Australia Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 37. Latin America Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 38. Latin America Anti-Aging Drugs and Devices Market Share by Country (2019-2030)

    Figure 39. Mexico Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 40. Brazil Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 41. Middle East & Africa Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 42. Middle East & Africa Anti-Aging Drugs and Devices Market Share by Country (2019-2030)

    Figure 43. Turkey Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 44. Saudi Arabia Anti-Aging Drugs and Devices Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 45. PrivateLabelSk Revenue Growth Rate in Anti-Aging Drugs and Devices Business (2019-2024)

    Figure 46. Allergan Revenue Growth Rate in Anti-Aging Drugs and Devices Business (2019-2024)

    Figure 47. Johnson and Johnson Revenue Growth Rate in Anti-Aging Drugs and Devices Business (2019-2024)

    Figure 48. Alma Lasers Revenue Growth Rate in Anti-Aging Drugs and Devices Business (2019-2024)

    Figure 49. Photomedex Revenue Growth Rate in Anti-Aging Drugs and Devices Business (2019-2024)

    Figure 50. Estée Lauder Revenue Growth Rate in Anti-Aging Drugs and Devices Business (2019-2024)

    Figure 51. Lumenis Revenue Growth Rate in Anti-Aging Drugs and Devices Business (2019-2024)

    Figure 52. Solta Medical Revenue Growth Rate in Anti-Aging Drugs and Devices Business (2019-2024)

    Figure 53. Beiersdorf Revenue Growth Rate in Anti-Aging Drugs and Devices Business (2019-2024)

    Figure 54. Cynosure Revenue Growth Rate in Anti-Aging Drugs and Devices Business (2019-2024)

    Figure 55. Procter & Gamble and L'Oréal Revenue Growth Rate in Anti-Aging Drugs and Devices Business (2019-2024)

    Figure 56. Bottom-up and Top-down Approaches for This Report

    Figure 57. Data Triangulation

    Figure 58. Key Executives Interviewed